Amended Statement of Beneficial Ownership (3/a)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

GOLL JOHN

2. Date of Event Requiring Statement (MM/DD/YYYY) 6/3/2019

3. Issuer Name and Ticker or Trading Symbol

INSMED Inc [INSM]

(Last) (First) (Middle)

700 US HIGHWAY 202/206

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Act. Off. & Controller /

(Street)

BRIDGEWATER, NJ 08807

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)
6/12/2019

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	6/2/2015	6/2/2024	Common Stock	25000	$12.58	D
Stock Option (right to buy)	1/8/2016	1/8/2025	Common Stock	12500	$16.07	D
Stock Option (right to buy)	5/21/2016	5/21/2025	Common Stock	37500	$22.76	D
Stock Option (right to buy)	1/7/2017	1/7/2026	Common Stock	11500	$16.16	D
Stock Option (right to buy)	5/19/2017	5/19/2026	Common Stock	17080	$10.85	D
Stock Option (right to buy)	1/5/2018	1/5/2027	Common Stock	15080	$13.67	D
Stock Option (right to buy)	5/17/2018	5/17/2027	Common Stock	12210	$17.16	D
Stock Option (right to buy)	1/4/2019	1/4/2028	Common Stock	11720	$30.46	D
Stock Option (right to buy)	1/3/2020	1/3/2029	Common Stock	27760	$13.91	D

Explanation of Responses:

Remarks:
This amendment includes stock option grants that were inadvertently omitted from the Reporting Person's initial Form 3 filed with the Securities and Exchange Commission on June 12, 2019.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
GOLL JOHN 700 US HIGHWAY 202/206 BRIDGEWATER, NJ 08807			Chief Act. Off. & Controller